Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Allegedly 1.2M vials- none of which are labeled?
FIRST OF ALL , ...
Every patients with covid is receiving 2 injections - 2 vials ,with each treatment.
Each vial they using is 350 mg dose , so each vial is half dose of 700 mg , and not 2 doses ..
So each time 2 vials needed ..2 injections are given of 350 mg each , each in different side of the abdomen..
Which mean every vials by this arrangement is about 700 mg ,
200,000 vials will be order , so if the same price time 700 doll.
This is a correct information if price was not change , ... so if only some will understand properly ..
This is a basic information...
dampening immunomodulators, which slow down an excessive immune reaction, could increasingly come onto the market in the near future.
Drug has been proven to save lives
The "wonder drug" stock having problems this morning?
dr Randy Nicolas was talking how nice price cydy offered Philippine at least for the first 100,000 vials
2,800.00 USD for 4 doses of Leronlimab ( they consider now as a treatment for one )
so leronlimab should be about 700 doll per vial
Lenzilumab is a GM-CSF inhibitor. The "M" of GM-CSF is macrophage.
CAR-T
https://www.nature.com/articles/s41408-021-00459-7
https://www.nature.com/articles/s41421-021-00255-4
https://www.targetedonc.com/view/lenzilumab-plus-axi-cel-achieves-responses-in-100-of-patients-with-dlbcl-with-limited-toxicity-in-small-study
https://www.healio.com/news/hematology-oncology/20210422/lenzilumab-before-cart-induces-high-response-rates-without-severe-toxicities
Covid
https://www.bbc.com/news/health-56352128
https://immunology.sciencemag.org/content/6/57/eabg9873
https://directorsblog.nih.gov/2021/04/13/mapping-severe-covid-19-in-the-lungs-at-single-cell-resolution/
https://www.nature.com/articles/s41586-021-03569-1
https://www.pharmaceutical-technology.com/news/humanigen-lenzilumab-improves-survival/
Lenzilumab pre-print just dropped
Fortunately Leronlimab is passing BBB
But please give me , just one anecdotal case like that with Lenzilumab , as we have hundreds of patients now with Leronlimab ..
My take on the paper is that this is a slam dunk for early
when for me saving lives is never anecdotal
Good results only in the studies done by Dr Fauci and Gilead...
They failed completely in China and WHO very large studies ..
......Results From WHO . ..
we could have changed end points until it fit successful end points and could have left the most critical out
Lenzilumab pre-print just dropped
Remdesivir is the Poster Child Classic representing the sick and corrupt slime of greedy and in this case evil human beings
Trial should fill fast as bad as things are in Brazil.
LL hasn't failed.
If it failed, you wouldn't need to be here daily trying to convince everyone. It would be self-evident.
So ironic, this statement being made about who owns the best drugs.
SWOV also relatively improved by 92% in subjects who received both corticosteroids and remdesivir
FDA knows results from Brazil will be stat sig imo
Lenzilumab pre-print just dropped
https://www.medrxiv.org/content/10.1101/2021.05.01.21256470v1
Hey Herpelitic Matt:
Lenzilumab improved the likelihood of SWOV by 54% in the mITT population (HR: 1.54; 95% CI: 1.02 to 2.31, p=0.041) and by 90% in the ITT population (HR: 1.90; 1.02 to 3.52, nominal p=0.043) compared to placebo.
WHERE is the money coming from
Not going to happen since a lender would never put a company out of business. Crazy Crazy
NP have a doctor/promoter in Brazil lined up yet?
How's that Philippines revenue coming?
The market has spoken. They do not approve. And there is nothing that Nader can say in today's cc that will help this situation. But there is plenty of things that he can say that will tank it. Tomorrow the stock price will likely trade between $2.40-$2.60.
Get out now! The call is coming from inside the house!
" Big Pharma does usually trials of 1000+ patients "
This is because their drugs are hardly working.
Misiu what I am most excited about is the number of patients. No more flack about not having enough
will cost cydy millions of dollars in free samples
120 critical patients in Brazil and we have an Interim during Oct-Nov?
Didnt lenzilmab finish study in Brazil also ,
Oh , you know that FDA only will accept Dr Fauci favorites here ,
yes , most probably you are right.
I am hoping they in talk with US FDA and Brazilian studies will be accepted here
The COVID-19 trials in Brazil are intended to provide the Brazilian regulatory authority, ANVISA, with the requisite data to consider advancing the availability of leronlimab to thousands of Brazilians infected with COVID-19.
ACTIV-1 IM (Immune Modulators) was launched with much fanfare in Oct 2020. It was to enroll approximately 2000 patients over a 6 month period. ie April 2021. Infliximab / Abatacept / Cenicriviroc were selected as the GAME CHANGERS.
Being run as an ADAPTIVE STUDY, they know EXACTLY how each drug is doing ..and have the power to change Endpoints with impunity. Why have we not heard the BRILLIANT RESULTS SO FAR..??
BECAUSE..
There is only one LERONLIMAB.
Long Covid Treatment: UK interview with Dr Patterson
HGEN's drug is lenzilumab. It is a GM-CSF inhibitor. The "M" in GM-CSF is macrophage.
CAR-T
https://www.nature.com/articles/s41408-021-00459-7
https://www.nature.com/articles/s41421-021-00255-4
https://www.targetedonc.com/view/lenzilumab-plus-axi-cel-achieves-responses-in-100-of-patients-with-dlbcl-with-limited-toxicity-in-small-study
https://www.healio.com/news/hematology-oncology/20210422/lenzilumab-before-cart-induces-high-response-rates-without-severe-toxicities
Covid
https://www.bbc.com/news/health-56352128
https://immunology.sciencemag.org/content/6/57/eabg9873
https://directorsblog.nih.gov/2021/04/13/mapping-severe-covid-19-in-the-lungs-at-single-cell-resolution/
https://www.nature.com/articles/s41586-021-03569-1
https://www.pharmaceutical-technology.com/news/humanigen-lenzilumab-improves-survival/
HGEN Summary
https://www.reddit.com/r/Humanigen/comments/n1a4q4/another_awesome_dd/
Yahoo shows $16.95
Typical HGEN casually down 6% AH
Patterson proffered Rantes as a member of Incellidex, he was a contractor to CYDY. That Independant scientific opinion would not fall under the auspices of the type of company specific regulatory issue regarding a company disclosure. Patterson opined that Rantes needed to be controlled to impact COVID. CYDY does not manufacture Rantes. Any company that dealt with Rantes could have been impacted by that info.